rs4029774
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000698776.1(STAT5B):c.-11+10844T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 152,136 control chromosomes in the GnomAD database, including 11,612 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 11612 hom., cov: 32)
Consequence
STAT5B
ENST00000698776.1 intron
ENST00000698776.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.427
Publications
19 publications found
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
- growth hormone insensitivity syndrome with immune dysregulationInheritance: SD Classification: DEFINITIVE Submitted by: Illumina
- growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- growth hormone insensitivity with immune dysregulation 1, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- growth hormone insensitivity syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.566 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STAT5B | ENST00000698776.1 | c.-11+10844T>C | intron_variant | Intron 1 of 18 | ENSP00000513923.1 | |||||
| STAT5B | ENST00000698777.1 | c.-11+11517T>C | intron_variant | Intron 1 of 18 | ENSP00000513924.1 | |||||
| STAT5B | ENST00000415845.2 | c.-326T>C | upstream_gene_variant | 4 | ENSP00000398379.2 |
Frequencies
GnomAD3 genomes AF: 0.366 AC: 55579AN: 152018Hom.: 11573 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
55579
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.366 AC: 55672AN: 152136Hom.: 11612 Cov.: 32 AF XY: 0.362 AC XY: 26950AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
55672
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
26950
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
23731
AN:
41500
American (AMR)
AF:
AC:
3276
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1169
AN:
3468
East Asian (EAS)
AF:
AC:
1859
AN:
5154
South Asian (SAS)
AF:
AC:
2066
AN:
4830
European-Finnish (FIN)
AF:
AC:
2513
AN:
10604
Middle Eastern (MID)
AF:
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19993
AN:
67964
Other (OTH)
AF:
AC:
776
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1737
3473
5210
6946
8683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1544
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.